In a 70-year-old male with diabetes who experiences dizziness and sweating after meals, has normal blood glucose, hypotension, and peripheral neuropathy treated with pregabalin 75 mg, what is the most likely diagnosis and appropriate treatment?

Diagnosis: Postprandial Hypotension Secondary to Diabetic Cardiovascular Autonomic Neuropathy

This patient is experiencing postprandial hypotension (PPH), a manifestation of diabetic cardiovascular autonomic neuropathy (CAN), likely exacerbated by pregabalin's hypotensive effects. The combination of dizziness and sweating after sugar intake, baseline hypotension (90/60 mmHg), diabetic peripheral neuropathy requiring treatment, and normal blood glucose (113 mg/dL) points directly to autonomic dysfunction affecting postprandial blood pressure regulation 1.

Clinical Reasoning

The key diagnostic features here are:

• Postprandial symptoms: Giddiness and sweating specifically after sugar intake is classic for PPH, defined as a systolic BP drop ≥20 mmHg within 2 hours of eating 2
• Baseline hypotension: BP of 90/60 mmHg indicates already compromised vascular tone
• Diabetic neuropathy: Foot numbness requiring pregabalin confirms peripheral neuropathy, which commonly coexists with autonomic neuropathy 1
• Normal glucose: Rules out hypoglycemia as the cause of symptoms

Important caveat: Pregabalin itself causes dizziness in 21% of diabetic neuropathy patients and can worsen hypotension 3. The timing of symptom onset (after starting pregabalin 75 mg) suggests the drug may be unmasking or worsening underlying autonomic dysfunction.

Immediate Management

Step 1: Confirm the Diagnosis

• Measure orthostatic vital signs (lying, sitting, standing at 1 and 3 minutes)
• Perform postprandial BP monitoring: measure BP before and at 15,30,60, and 90 minutes after a carbohydrate-rich meal
• Look for systolic BP drop ≥20 mmHg to confirm PPH 2

Step 2: Non-Pharmacological Interventions (First-Line)

Implement these measures immediately 1:

• Dietary modifications:

  • Avoid large carbohydrate-rich meals
  • Eat smaller, more frequent meals (5-6 per day)
  • Reduce simple sugars that cause rapid glucose absorption

• Fluid and salt management:

  • Increase fluid intake to 2-2.5 liters daily (if not contraindicated)
  • Increase salt intake (unless heart failure or uncontrolled hypertension present)
  • Drink 300-500 mL water rapidly before meals

• Physical countermaneuvers:

  • Remain seated for 30-60 minutes after meals
  • Use leg-crossing, squatting, or muscle tensing if symptoms occur
  • Elevate head of bed 30-45 degrees at night

• Compression garments: Elastic stockings over legs and abdomen to reduce venous pooling

Step 3: Consider Pregabalin Adjustment

Evaluate whether to continue pregabalin 3:

• Pregabalin causes dizziness (21%), somnolence (12%), and peripheral edema (9%) in diabetic neuropathy patients
• These side effects can compound hypotensive symptoms
• If neuropathic pain is well-controlled, consider reducing dose to 50 mg or switching to alternative (duloxetine, which may have less hypotensive effect)
• If pain control is inadequate, maintain current dose but intensify non-pharmacological measures

Step 4: Pharmacological Treatment for PPH (If Non-Pharmacological Measures Fail)

First-line pharmacological options 1:

1. Caffeine 150-200 mg before meals:

   • Prevents postprandial BP drop by increasing plasma noradrenaline 4
   • Simple, well-tolerated, and effective
   • Can be given as coffee or caffeine tablets

2. Acarbose:

   • Slows carbohydrate absorption, attenuating postprandial hypotension 1
   • Particularly useful in diabetic patients as it also improves glycemic control

If symptoms persist despite above measures 1:

1. Midodrine 2.5-10 mg three times daily (Level A evidence):

   • Take first dose before arising, avoid within 4 hours of bedtime
   • FDA-approved for orthostatic hypotension
   • Monitor for supine hypertension

2. Fludrocortisone 0.05-0.1 mg daily (Level B evidence):

   • Titrate to 0.1-0.3 mg daily as needed
   • Monitor potassium, watch for edema and heart failure

Critical Pitfalls to Avoid

1. Do not assume hypoglycemia: Blood glucose is 113 mg/dL; symptoms are vascular, not metabolic
2. Do not discontinue pregabalin abruptly: Taper if adjustment needed to avoid withdrawal
3. Do not ignore supine hypertension risk: When treating orthostatic/postprandial hypotension pharmacologically, monitor supine BP to avoid marked elevation 1
4. Do not overlook medication review: Identify and discontinue drugs worsening hypotension (diuretics, alpha-blockers, psychotropics) 1

Monitoring Plan

• Daily BP log: before and after meals, lying and standing
• Weekly follow-up initially to assess response to interventions
• Adjust pregabalin based on pain control versus side effect burden
• Escalate to pharmacological therapy only if non-pharmacological measures fail after 2-4 weeks 1